HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 47.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 33,589 shares of the company’s stock after selling 30,871 shares during the period. Los Angeles Capital Management LLC’s holdings in HealthEquity were worth $2,227,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. FMR LLC boosted its stake in HealthEquity by 19.1% in the third quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after acquiring an additional 907,743 shares in the last quarter. Mackenzie Financial Corp increased its position in HealthEquity by 58.2% during the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock worth $119,831,000 after buying an additional 664,979 shares during the period. Invesco Ltd. lifted its stake in HealthEquity by 164.6% in the third quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock valued at $35,359,000 after buying an additional 301,078 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of HealthEquity by 12.1% in the third quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company’s stock valued at $161,051,000 after acquiring an additional 238,116 shares during the period. Finally, Eagle Asset Management Inc. purchased a new position in shares of HealthEquity during the third quarter worth approximately $15,581,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

HQY stock opened at $79.27 on Tuesday. The firm has a 50 day moving average of $80.72 and a 200-day moving average of $74.67. The company has a market cap of $6.80 billion, a price-to-earnings ratio of 123.86, a PEG ratio of 1.28 and a beta of 0.55. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. HealthEquity, Inc. has a 12-month low of $53.15 and a 12-month high of $84.49.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. As a group, equities analysts expect that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HQY. Barclays increased their price target on shares of HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research note on Friday, February 23rd. Royal Bank of Canada upped their price objective on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, March 20th. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price target on shares of HealthEquity in a report on Friday, March 22nd. BTIG Research boosted their price objective on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Finally, JMP Securities started coverage on shares of HealthEquity in a research note on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 target price for the company. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $96.17.

Insider Buying and Selling

In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, EVP Delano Ladd sold 2,558 shares of HealthEquity stock in a transaction on Friday, March 1st. The shares were sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares in the company, valued at approximately $3,917,904.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now directly owns 126,635 shares in the company, valued at $10,106,739.35. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,322 shares of company stock worth $5,682,895. 2.70% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.